results of maintenance therapy in high-risk myeloma patients | ajay nooka, md, mph, facp | asco 2023
Published 1 year ago • 862 plays • Length 6:23
Download video MP4
Download video MP3
Similar videos
-
5:54
efficacy and safety of elranatamab | ajay nooka, md, mph, facp | asco 2023
-
57:49
know your myeloma therapy: what's available for maintenance therapy?
-
1:03:51
the question of maintenance therapy: for whom and how long?
-
3:37
induction therapy followed by kyprolis maintenance vs no maintenance | heinz ludwig, md | eha 2022
-
23:03
how myeloma frontline therapy is changing - ajai chari, md | rt irvine, ca nov 5, 2022
-
4:20
what were the results of the determination trial presented at asco and eha?
-
1:35
the impact of frontline maintenance therapy on myeloma patients in the uk
-
1:16:10
myeloma crowd radio: dr. ajay nooka, md, mph, facp, emory winship ci
-
1:26:56
studying the relationship between myeloma progression and diet
-
59:57
what's available for induction therapy in multiple myeloma
-
5:17
immunotherapy | high impact topic (hit)
-
2:47
results from the optimum/muknine trial | martin kaiser, md, frcp, frcpath | ash 2023
-
1:54
why consider maintenance therapy if i am in a complete response?
-
18:53
2020 winship scientific symposium | ajay nooka, md, mph and larry boise, phd
-
2:27
dr. ravi vij discussing with dr. ajay nooka md on multiple myeloma initial treatment @mycancerhaven
-
28:06
use of maintenance therapy following asct and real world treatment patterns in multiple myeloma
-
3:24
ajay nooka, md, facp, on the fda accelerated approval of elranatamab
-
4:19
optimum muk nine trial | martin kaiser, md | ash 2022
-
0:53
asco24 direct highlights | saurin a chokshi, md
-
3:01
cost per responder analysis of multiple myeloma patients | doris k hansen, md | ash 2023 #myeloma
-
2:47:42
accelerating toward curing myeloma: new data, new agents, and evolving treatment paradigm
-
0:59
monoclonal antibodies: a potential treatment for #covid19
Clip.africa.com - Privacy-policy